Reuters logo
Sanofi may appeal French competition body fine
May 14, 2013 / 8:21 AM / 4 years ago

Sanofi may appeal French competition body fine

PARIS, May 14 (Reuters) - French drugmaker Sanofi said on Tuesday it objected to a fine by the French Competition Authority in a dispute over generic competition to its blood thinner, Plavix, and said it was considering a possible appeal.

The Competition Authority said it fined Sanofi 40.6 million euros ($52.7 million) over what it called a smear campaign aimed at stifling generic competition to Plavix. ($1 = 0.7703 euros) (Reporting by Dominique Vidalon; Editing by James Regan)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below